期刊
GENES & DEVELOPMENT
卷 24, 期 12, 页码 1281-1294出版社
COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.585710
关键词
Myc; Miz1; senescence; TGF beta; lymphoma; T-cell
资金
- Deutsche Forschungsgemeinschaft
- Sander-Stiftung
- Lymphoma Research Foundation
- NIH
- Leukemia and Lymphoma Society
- Burroughs Wellcome Fund
The Myc protein suppresses the transcription of several cyclin-dependent kinase inhibitors (CKIs) via binding to Miz1; whether this interaction is important for Myc's ability to induce or maintain tumorigenesis is not known. Here we show that the oncogenic potential of a point mutant of Myc (MycV394D) that is selectively deficient in binding to Miz1 is greatly attenuated. Binding of Myc to Miz1 is continuously required to repress CKI expression and inhibit accumulation of trimethylated histone H3 at Lys 9 (H3K9triMe), a hallmark of cellular senescence, in T-cell lymphomas. Lymphomas that arise express high amounts of transforming growth factor beta-2 (TGF beta-2) and TGF beta-3. Upon Myc suppression, TGF beta signaling is required to induce CKI expression and cellular senescence and suppress tumor recurrence. Binding of Myc to Miz1 is required to antagonize growth suppression and induction of senescence by TGF beta. We demonstrate that, since lymphomas express high levels of TGF beta, they are poised to elicit an autocrine program of senescence upon Myc inactivation, demonstrating that TGF beta is a key factor that establishes oncogene addiction of T-cell lymphomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据